NSE Seeks Clarification From Supriya Lifescience Over June Quarter Results

Generic user silhouette icon 5paisa Capital Ltd - 0 min read

Last Updated: 23rd September 2026 - 05:54 pm

The National Stock Exchange is requesting clarification regarding the financial results of Supriya Lifescience for the period ending June 30, 2026. 

This matter pertains to Regulation 33 of SEBI’s Listing Obligations and Disclosure Requirements Regulations that deals with the submission of financial results by listed firms. 

Supriya Lifescience had announced its financial results for the June quarter in August, along with a newspaper publication as well. 

A company communication dated September 5, 2026 refers to the clarification sought by the NSE. However, the copy made available for this article is incomplete and ends before Supriya Lifescience’s detailed response. 

As a result, the precise observation raised by the exchange, and the company’s explanation addressing it, cannot be established from the available material. 

The matter therefore remains limited, on the information available, to an exchange clarification relating to Supriya Lifescience’s June-quarter financial-results filing. No further conclusion can be drawn from the disclosure provided. 

FREE Trading & Demat Account
Open FREE Demat Account with endless opportunities.
  • Flat ₹20 Brokerage
  • Next-gen Trading
  • Advanced Charting
  • Actionable Ideas
+91
''
By proceeding, you agree to our T&Cs*
Mobile No. belongs to
OR
hero_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form